Michael VanPelt spent the spring glued to his telephone, dialing doctors who might be able to get his 3-year-old son in for ...

STAT editors and reporters review the widespread impact of grant cuts, layoffs and policy changes — and also discuss recent ...

Biotech leaders at a Stanford symposium normally focused on the future couldn’t help but grapple with a present clouded by ...

This is the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...

HHS released a lengthy review of transgender health care that advocates for a greater reliance on behavioral therapy rather ...

Democratic lawmakers in Congress are pushing back on health secretary Robert F. Kennedy Jr.’s decision to suspend public ...

For the second time in recent months, the FDA is bringing back some recently fired employees, including staffers who handle ...

From STAT’s Jason Mast: Moderna said this morning in its earnings report it planned to cut costs by around $1.5 billion by ...

Eli Lilly shares dropped Thursday as Novo Nordisk notched a coverage win for its obesity drug, a sign of the competition in ...

CVS Health will not sell its Aetna health plans in the Affordable Care Act’s individual marketplaces in 2026, marking the ...

The CDC posted an annual HIV report on Tuesday. It was slimmer than usual. The CDC said that a usual estimate of the ...

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to ...